# A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

> **NCT03911128** · — · RECRUITING · sponsor: **Mats Heyman** · enrollment: 500 (estimated)

## Conditions studied

- Leukemia, Acute Lymphoblastic

## Interventions

- **OTHER:** Observational

## Key facts

- **NCT ID:** NCT03911128
- **Lead sponsor:** Mats Heyman
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-08-29
- **Primary completion:** 2033-06
- **Final completion:** 2033-06
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-09-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03911128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03911128, "A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03911128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*